COMPARATIVE-EFFECTIVENESS RESEARCH IN SUPPORT OF EVIDENCE-BASED DECISIONS

摘要

DOES COMPARATIVE-EFFECTIVENESS RESEARCH NEED TO CONSIDER COSTS?:"Payers have a fiduciary responsibility on behalf of their members and clients," according to David Clark, RPh, MBA, President of VisumRx. Panel members highlighted the need for comparative-effectiveness research (CER) that will help differentiate costs, which will help inform the cost aspects of coverage decision making.